Encapsulating peritoneal sclerosis following renal transplantation despite tamoxifen and immunosuppressive therapy

NDT Plus

Volumn 1, Issue 5, 2008, Pages 333-335

  De Freitas, Declan ^a   Augustine, Titus ^a   Hurst, Helen ^a   Taylor, Paul ^a   Williams, Rosalind ^a   Hutchison, Alastair ^a   Brenchley, Paul E C ^a   Summers, Angela M ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

EPS; Immunosuppression; Tamoxifen; Transplantation

Indexed keywords

BARIUM; BASILIXIMAB; CONTRAST MEDIUM; METHYLPREDNISOLONE; NETILMICIN; PREDNISOLONE; TACROLIMUS; TAMOXIFEN; VANCOMYCIN;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHOLECYSTECTOMY; CHOLECYSTITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; ENCAPSULATING PERITONEAL SCLEROSIS; HEMODIALYSIS; HISTOPATHOLOGY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE OBSTRUCTION; IRRITABLE COLON; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LABORATORY TEST; MALE; MONOTHERAPY; PERITONEAL BIOPSY; PERITONITIS; PRIORITY JOURNAL; SCLEROSIS;

EID: 52449083421     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfn109     Document Type: Article

References (12)

1. Kawanishi H, Moriishi M. Epidemiology of encapsulating peritoneal sclerosis in Japan. Perit Dial Int 2005; 25(Suppl 4): S14-S18
2. Summers AM, Clancy MJ, Syed F et al. Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure 1. Kidney Int 2005; 68: 2381-2388
3. de Freitas D, Jordaan A, Brenchley PEC et al. Encapsulating peritoneal sclerosis (EPS) following renal transplantation. Perit Dial Int 2006; 26(Suppl 2): S116
4. Fieren MW, Betjes MG, Korte MR et al. Posttransplant encapsulating peritoneal sclerosis: a worrying new trend? Perit Dial Int 2007; 27: 619-624
5. Allaria PM, Giangrande A, Gandini E et al. Continuous ambulatory peritoneal dialysis and sclerosing encapsulating peritonitis: tamoxifen as a new therapeutic agent? J Nephrol 1999; 12: 395-397
6. del PG, Bajo MA, Gil F et al. Clinical experience with tamoxifen in peritoneal fibrosing syndromes. Adv Perit Dial 2003; 19: 32-35
7. Moustafellos P, Hadjianastassiou V, Roy D et al. Tamoxifen therapy in encapsulating sclerosing peritonitis in patients after kidney transplantation. Transplant Proc 2006; 38: 2913-2914
8. Kinzbrunner B, Ritter S, Domingo J et al. Remission of rapidly growing desmoid tumors after tamoxifen therapy. Cancer 1983; 52: 2201-2204
9. Junor BJ, McMillan MA. Immunosuppression in sclerosing peritonitis. Adv Perit Dial 1993; 9: 187-189
10. Bhandari S. Recovery of gastrointestinal function after renal transplantation in patients with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996; 27: 604
11. Hawley CM, Wall DR, Johnson DW et al. Recovery of gastrointestinal function after renal transplantation in a patient with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1995; 26: 658-661
12. Summers AM, Brenchley PEC. An international encapsulating peritoneal sclerosis registry and DNA Bank. Why we need one now? Perit Dial Int 2006; 26: 559-563